Meda(Pharmaceuticals) Overview

  • Status
  • Acquired/​Merged

  • Employees
  • 4,500

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 8

  • Investments
  • 32

Meda(Pharmaceuticals) General Information

Description

Manufacturer of pharmaceutical products intended for the treatment and management of various medical conditions. The company offers a portfolio of branded and generic medicines supported by regulatory, marketing, and distribution capabilities, enabling healthcare providers and patients to access effective and reliable therapeutic services.

Contact Information

Website
www.meda.se
Formerly Known As
MedPointe
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Pipers Väg 2A
  • 170 09 Solna
  • Sweden
Primary Industry
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • Pipers Väg 2A
  • 170 09 Solna
  • Sweden

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Meda(Pharmaceuticals) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Meda(Pharmaceuticals)‘s full profile, request access.

Request a free trial

Meda(Pharmaceuticals) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of pharmaceutical products intended for the treatment and management of various medical conditions. The com
Pharmaceuticals
Solna, Sweden
4,500 As of 2016

Hauppauge, NY

Friedrichsdorf, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Meda(Pharmaceuticals) Competitors (81)

One of Meda(Pharmaceuticals)’s 81 competitors is LNK International, a Corporation company based in Hauppauge, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
LNK International Corporation Hauppauge, NY
axicorp Corporate Backed or Acquired Friedrichsdorf, Germany
Rottendorf Pharma Corporation Ennigerloh, Germany
Aytu Biopharma Corporation Denver, CO
Moberg Pharma Formerly VC-backed Bromma, Sweden
You’re viewing 5 of 81 competitors. Get the full list »

Meda(Pharmaceuticals) Patents

Meda(Pharmaceuticals) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202319896-D0 Oral care preparations Inactive 22-Dec-2023
AU-2020205463-A1 Oral care preparations comprising chlorhexidine and arginine or their salts Inactive 11-Jan-2019
EP-3697380-A1 Oral care preparations comprising chlorhexidine and arginine or their salts Active 11-Jan-2019
EP-3697380-B1 Oral care preparations comprising chlorhexidine and arginine or their salts Active 11-Jan-2019
EP-3721862-A1 Oral care preparations comprising chlorhexidine and arginine or their salts Active 11-Jan-2019 A61K8/43
To view Meda(Pharmaceuticals)’s complete patent history, request access »

Meda(Pharmaceuticals) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Meda(Pharmaceuticals) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Meda(Pharmaceuticals)‘s full profile, request access.

Request a free trial

Meda(Pharmaceuticals) Investments & Acquisitions (32)

Meda(Pharmaceuticals)’s most recent deal was a Grant with Gtlyfe for . The deal was made on 11-Oct-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Gtlyfe 11-Oct-2018 Grant Application Software
BCM Holdings 26-Feb-2017 Merger/Acquisition Real Estate Services (B2C)
Rottapharm 10-Oct-2014 Merger/Acquisition Pharmaceuticals
Zpearpoint 19-Dec-2013 Merger/Acquisition Pharmaceuticals
Acton Pharmaceuticals 21-Oct-2013 Merger/Acquisition Pharmaceuticals
You’re viewing 5 of 32 investments and acquisitions. Get the full list »

Meda(Pharmaceuticals) Exits (3)

Meda(Pharmaceuticals)’s most recent exit was on 11-Oct-2018 from Gtlyfe. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Gtlyfe 11-Oct-2018 Completed
BCM Holdings 26-Feb-2017 Completed
Ceplene (exclusive rights) 01-Jan-2010 Corporate Asset Purchase Completed
To view Meda(Pharmaceuticals)’s complete exits history, request access »

Meda(Pharmaceuticals) Affiliates

Subsidiaries (4)

Name Industry Location Year Founded
Mylan Sweden Holdings Stockholm, Sweden 2016
MidNite (Pharmaceuticals) Solna, Sweden 2002
Scandinavian Pharmaceuticals-Generics Stockholm, Sweden 1983
Ellem Läkemedel Danderyd, Sweden 1978

Meda(Pharmaceuticals) FAQs

  • Where is Meda(Pharmaceuticals) headquartered?

    Meda(Pharmaceuticals) is headquartered in Solna, Sweden.

  • What is the size of Meda(Pharmaceuticals)?

    Meda(Pharmaceuticals) has 4,500 total employees.

  • What industry is Meda(Pharmaceuticals) in?

    Meda(Pharmaceuticals)’s primary industry is Pharmaceuticals.

  • Is Meda(Pharmaceuticals) a private or public company?

    Meda(Pharmaceuticals) is a Private company.

  • What is the current valuation of Meda(Pharmaceuticals)?

    The current valuation of Meda(Pharmaceuticals) is .

  • What is Meda(Pharmaceuticals)’s current revenue?

    The current revenue for Meda(Pharmaceuticals) is .

  • How much funding has Meda(Pharmaceuticals) raised over time?

    Meda(Pharmaceuticals) has raised $3.06B.

  • Who are Meda(Pharmaceuticals)’s investors?

    Fidim, Nordic Capital, Priveq Investment, and Stena Sessan have invested in Meda(Pharmaceuticals).

  • Who are Meda(Pharmaceuticals)’s competitors?

    LNK International, axicorp, Rottendorf Pharma, Aytu Biopharma, and Moberg Pharma are some of the 81 competitors of Meda(Pharmaceuticals).

  • When was Meda(Pharmaceuticals) acquired?

    Meda(Pharmaceuticals) was acquired on 05-Aug-2016.

  • Who acquired Meda(Pharmaceuticals)?

    Meda(Pharmaceuticals) was acquired by Mylan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process